Moderna

NASDAQ Composite and global tech market volatility

15 clusters · 226 sources · last updated about 5 hours ago

Latest: AI spending concerns impact emerging market currencies

The NASDAQ Composite and broader global equity markets experienced a significant downturn in mid-October 2026, driven by growing concerns regarding the sustainability of artificial intelligence (AI) infrastructure spendi

US stock market volatility and rising Treasury yields

21 clusters · 229 sources · last updated about 22 hours ago

Latest: S&P 500 market trends and algorithmic forecasting

By late October 2026, the S&P 500 has navigated significant volatility driven by high valuations and concerns over market concentration. While the index maintained a year-to-date increase of approximately 12% to 13.8%, a

SanDisk AI rally continues amid index inclusion and risks

49 clusters · 101 sources · last updated 1 day ago

Latest: NAND Flash manufacturers report surging demand driven by AI

SanDisk’s AI-driven rally has seen its stock rise over 3,900% in twelve months, exceeding $1,550. Following its February 2025 separation from Western Digital, the company has become a top performer in the S&P 500. In Sep

OpenAI GPT-Rosalind life sciences model expansion

3 clusters · 7 sources · last updated 1 day ago

Latest: OpenAI restricts access to GPT-Rosalind-6 biology model

OpenAI has begun structuring its GPT-Rosalind series into a specialized product line for the life sciences sector. Following the introduction of pricing for the gpt-rosalind-discovery and gpt-rosalind-research models, th

Scientific reviews of mRNA technology safety

2 clusters · 6 sources · last updated 2 days ago

Latest: Researchers examine mRNA vaccine persistence and lipid nanoparticle effects

Scientific literature reviews published in late October 2026 have evaluated the safety and toxicological profiles of modified mRNA technology. A review in the Journal of Toxicology examined research from 2020 to 2026,

Solana price volatility amid RWA growth and ETF outflows

51 clusters · 129 sources · last updated 3 days ago

Latest: Ethereum and Solana face selling pressure amid ETF outflows

Solana has transitioned from technical uncertainty toward significant institutional and ecosystem growth, though price volatility remains high. In August 2026, the SOL token broke above $100, supported by record-breaking

DRC Ebola outbreak expands and impacts healthcare workers

439 clusters · 3350 sources · last updated 3 days ago

Latest: Belgium deploys mobile laboratory to Congo to combat Ebola outbreak

The Bundibugyo-strain Ebola outbreak in the Democratic Republic of Congo (DRC) continues to escalate, marking one of the deadliest epidemics in the country’s history. As of late October 2026, confirmed cases have surpass

Early Northern Hemisphere influenza surge and G155E mutation

9 clusters · 45 sources · last updated 3 days ago

Latest: Health experts warn of seasonal flu and COVID-19 surges

Public health officials in the Northern Hemisphere are reporting an unusually early onset of influenza activity. In the United States, the surge is notably driven by the West Coast rather than the South. Surveillance dat

Taiwan expands influenza and COVID-19 vaccine eligibility

20 clusters · 22 sources · last updated 3 days ago

Latest: Taiwan expands influenza and COVID-19 vaccine eligibility

Taiwan continues to face a complex infectious disease landscape as influenza and enterovirus outbreaks rise. While COVID-19 cases previously trended downward, influenza severity has recently surged. The CDC reported 219

Moderna and Merck melanoma vaccine clinical trials

19 clusters · 558 sources · last updated 3 days ago

Latest: BioNTech and Moderna face mixed clinical and market outlooks

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon

Respiratory virus vaccination guidance and developments

21 clusters · 77 sources · last updated 4 days ago

Latest: Ontario launches free flu and COVID-19 vaccine rollout

The respiratory virus vaccination season is underway across North America and globally, with a focus on influenza, COVID-19, and RSV. In the United States, Moderna’s mRNA-based mFLUSIVA is available for adults aged 50 an

ESMO 2026 oncology congress developments

3 clusters · 86 sources · last updated 4 days ago

Latest: ESMO Congress reveals major advancements in cancer treatment

The European Society for Medical Oncology (ESMO) 2026 congress in Madrid presented various phase 3 clinical trial results across multiple cancer types. Initial reports highlighted advancements in melanoma, where combini

mRNA technology and personalized cancer vaccine research

3 clusters · 117 sources · last updated 4 days ago

Latest: Merck and Moderna mRNA vaccine reduces melanoma recurrence risk

Recent medical research highlights significant progress in using messenger RNA (mRNA) technology to develop personalized cancer vaccines. These vaccines utilize a patient’s specific tumor mutations or neoantigens to trai

Global spread and rising infections of XFG Stratus variant

9 clusters · 28 sources · last updated 5 days ago

Latest: COVID-19 XFG variant predominates in Mexico

The XFG COVID-19 variant, nicknamed ‘Stratus’, ‘American Covid’, or ‘Frankenstein’, continues to spread globally. This recombinant strain, formed from the mixing of Omicron subvariants LF.7 and LP.8.1.2, has been identif

Mexico public health and vaccination initiatives

9 clusters · 80 sources · last updated 9 days ago

Latest: Mexico launches national winter vaccination campaign

The Mexican government is executing a broad public health strategy focused on vaccination campaigns and infrastructure expansion. For the 2026-2027 winter season, the administration is utilizing Pfizer and Moderna vaccin

Advances and challenges in mRNA and immunotherapy trials

11 clusters · 25 sources · last updated 10 days ago

Latest: Immunotherapy advancements show promise in treating colorectal and melanoma cancers

Cancer immunotherapy is evolving through personalized mRNA vaccines and cellular therapies. Recent breakthroughs include a platform generating T-cells from hematopoietic stem cells, which offers a ready-to-use alternativ

AI integration in life sciences and clinical practice

2 clusters · 24 sources · last updated 13 days ago

Latest: OpenAI acquires biotech startup Orchestra Bio

The life sciences and healthcare sectors are increasingly integrating artificial intelligence to optimize drug development and clinical workflows. Oracle and AstraZeneca have entered a non-binding agreement to utilize A

German public expenditure trends

3 clusters · 35 sources · last updated 14 days ago

Latest: Germany faces rising costs amid EU migration policy shifts

Recent reports highlight significant fiscal pressures within Germany across different sectors. Healthcare expenditures reached a record 528.5 billion euros in 2024, driven largely by demographic shifts where individuals

Taiwan public health and vaccination initiatives

10 clusters · 15 sources · last updated 19 days ago

Latest: Taiwan expands vaccine options as influenza and COVID-19 shots surge

Taiwan is expanding its public health initiatives through large-scale vaccine procurement and the introduction of digital incentive programs. The Centers for Disease Control announced a record procurement of over 7 milli

Vaccination campaigns in Mexico

2 clusters · 5 sources · last updated 21 days ago

Latest: Vaccination campaigns launch in Sinaloa and Tocoa

Health authorities in Mexico have initiated winter vaccination campaigns to address seasonal illnesses. In Campeche, officials launched an intensive drive following a rise in acute respiratory infections, which saw betwe

Stock market volatility and sector performance

2 clusters · 7 sources · last updated 21 days ago

Latest: Various technology and industrial stocks face volatility

Market volatility has prompted investor scrutiny of various sectors, particularly within the S&P 500 and technology industries. Early reports highlighted the performance of companies like Sandisk, Moderna, and Dell Techn

Poland COVID-19 and seasonal vaccination guidelines 2026/27

9 clusters · 33 sources · last updated 25 days ago

Latest: Poland faces early respiratory infection season and healthcare access challenges

The Polish Ministry of Health has initiated the 2026/2027 COVID-19 vaccination campaign, with supply distribution for individuals aged 12 and older beginning on September 11. Pediatric versions of the Spikevax XFG vaccin